Works matching IS 0195668X AND DT 2022 AND VI 43 AND IP 31

Results: 18

What cardiologists should know about sleep.

Published in:

European Heart Journal, 2022, v. 43, n. 31, p. 2911, doi. 10.1093/eurheartj/ehac349

By:

Pengo, Martino Francesco;
Javaheri, Sogol;
Sanchez-de-la-Torre, Manuel;
Schwarz, Esther Irene

Publication type:

Article

far-reaching beneficial effects of sodium–glucose co-transporter 2 inhibitors in heart failure.

Published in:

European Heart Journal, 2022, v. 43, n. 31, p. 2907, doi. 10.1093/eurheartj/ehac437

By:

Crea, Filippo

Publication type:

Article

UK TAVI trial: an independent, pragmatic study extending the evidence for the treatment of symptomatic severe aortic stenosis.

Published in:

European Heart Journal, 2022, v. 43, n. 31, p. 2919, doi. 10.1093/eurheartj/ehac345

By:

Vergallo, Rocco;
Volpe, Massimo

Publication type:

Article

Left main revascularization: breaking through the sounds of silence.

Published in:

European Heart Journal, 2022, v. 43, n. 31, p. 2998, doi. 10.1093/eurheartj/ehac340

By:

Gaudino, Mario;
Farkouh, Michael E;
Stone, Gregg W

Publication type:

Article

Post-operative AF and heart failure hospitalizations: what remains hidden in patients undergoing surgery.

Published in:

2022

By:

Middeldorp, Melissa E;
Albert, Christine M

Publication type:

Editorial

sounds of silence.

Published in:

European Heart Journal, 2022, v. 43, n. 31, p. 2997, doi. 10.1093/eurheartj/ehac333

By:

Parolari, Alessandro;
Almeida, Rui M S;
Boden, William E;
group, INTEGRITTY (INTernational Evidence Grading Research Initiative Targeting Transparency and data qualitY)

Publication type:

Article

Popeye's sign and transthyretin amyloidosis.

Published in:

2022

By:

Tahara, Nobuhiro;
Honda, Akihiro;
Ueda, Mitsuharu;
Fukumoto, Yoshihiro

Publication type:

Abstract

Paroxysmal massive mitral regurgitation.

Published in:

2022

By:

Wei, Xin;
Zhou, Minggang;
Chen, Yong;
Chen, Mao

Publication type:

Case Study

Frankfurt scientists lead the way with funding for three visionary research projects.

Published in:

European Heart Journal, 2022, v. 43, n. 31, p. 2914, doi. 10.1093/eurheartj/ehac316

By:

Ozkan, Judith

Publication type:

Article

Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled.

Published in:

European Heart Journal, 2022, v. 43, n. 31, p. 2984, doi. 10.1093/eurheartj/ehac306

By:

Ferreira, João Pedro;
Zannad, Faiez;
Butler, Javed;
Filipattos, Gerasimos;
Ritter, Ivana;
Schüler, Elke;
Kraus, Bettina J;
Pocock, Stuart J;
Anker, Stefan D;
Packer, Milton

Publication type:

Article

Emerging role for SGLT2 inhibitors in mitigating the risk of hyperkalaemia in heart failure.

Published in:

European Heart Journal, 2022, v. 43, n. 31, p. 2994, doi. 10.1093/eurheartj/ehac304

By:

Verma, Subodh;
Dhingra, Nitish K;
Pandey, Arjun K;
Cosentino, Francesco

Publication type:

Article

Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease.

Published in:

European Heart Journal, 2022, v. 43, n. 31, p. 2931, doi. 10.1093/eurheartj/ehac299

By:

Pandey, Arjun K;
Bhatt, Deepak L;
Cosentino, Francesco;
Marx, Nikolaus;
Rotstein, Ori;
Pitt, Bertram;
Pandey, Ambirash;
Butler, Javed;
Verma, Subodh

Publication type:

Article

Anti-interleukin-1 agents for pericarditis: a primer for cardiologists.

Published in:

European Heart Journal, 2022, v. 43, n. 31, p. 2946, doi. 10.1093/eurheartj/ehab452

By:

Imazio, Massimo;
Lazaros, George;
Gattorno, Marco;
LeWinter, Martin;
Abbate, Antonio;
Brucato, Antonio;
Klein, Allan

Publication type:

Article

multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO Consortium.

Published in:

European Heart Journal, 2022, v. 43, n. 31, p. 2916, doi. 10.1093/eurheartj/ehac265

By:

Johnsen, Søren P;
Proietti, Marco;
Maggioni, Aldo P;
Lip, Gregory Y H

Publication type:

Article

Critical appraisal of artificial intelligence-based prediction models for cardiovascular disease.

Published in:

European Heart Journal, 2022, v. 43, n. 31, p. 2921, doi. 10.1093/eurheartj/ehac238

By:

Smeden, Maarten van;
Heinze, Georg;
Calster, Ben Van;
Asselbergs, Folkert W;
Vardas, Panos E;
Bruining, Nico;
Jaegere, Peter de;
Moore, Jason H;
Denaxas, Spiros;
Boulesteix, Anne Laure;
Moons, Karel G M

Publication type:

Article

Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE–TIMI 58 trial.

Published in:

European Heart Journal, 2022, v. 43, n. 31, p. 2958, doi. 10.1093/eurheartj/ehab530

By:

Oyama, Kazuma;
Raz, Itamar;
Cahn, Avivit;
Kuder, Julia;
Murphy, Sabina A;
Bhatt, Deepak L;
Leiter, Lawrence A;
McGuire, Darren K;
Wilding, John P H;
Park, Kyong Soo;
Goudev, Assen;
Diaz, Rafael;
Špinar, Jindřich;
Gause-Nilsson, Ingrid A M;
Mosenzon, Ofri;
Sabatine, Marc S;
Wiviott, Stephen D

Publication type:

Article

Post-operative atrial fibrillation and risk of heart failure hospitalization.

Published in:

European Heart Journal, 2022, v. 43, n. 31, p. 2971, doi. 10.1093/eurheartj/ehac285

By:

Goyal, Parag;
Kim, Michael;
Krishnan, Udhay;
Mccullough, Stephen A;
Cheung, Jim W;
Kim, Luke K;
Pandey, Ambarish;
Borlaug, Barry A;
Horn, Evelyn M;
Safford, Monika M;
Kamel, Hooman

Publication type:

Article

Obesity, heart failure, and SGLT2 inhibition: DECLARE-TIMI 58 provides insights.

Published in:

European Heart Journal, 2022, v. 43, n. 31, p. 2968, doi. 10.1093/eurheartj/ehab709

By:

Sattar, Naveed;
Anker, Stefan D;
Butler, Javed;
Verma, Subodh

Publication type:

Article